Valuation: ConvaTec Group Plc

Market Cap 6.35B 5.7B 5.27B 4.77B 8.91B 605B 9.02B 62.96B 25.08B 316B 23.82B 23.32B 1,004B P/E 2026 *
25x
P/E 2027 * 17.2x
Enterprise Value 7.75B 6.95B 6.43B 5.82B 10.88B 738B 11.01B 76.86B 30.61B 386B 29.08B 28.47B 1,226B EV / Sales 2026 *
3.03x
EV / Sales 2027 * 2.77x
Free-Float
95.08%
Yield 2026 *
2.46%
Yield 2027 * 2.81%
1 day+1.33%
1 week+1.67%
Current month+12.44%
1 month+15.09%
3 months+6.92%
6 months+12.24%
Current year+0.33%
1 week 239.6
Extreme 239.6
247.5
1 month 211
Extreme 211
247.5
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Date Insider Type Main position Quantity % Market Cap. Importance
10/13/26 Buy

Director

24,400 0.0013%
5/26/26 Buy

Chief Executive Officer

50,000 0.0026%
5/26/26 Buy

Chief Financial Officer

24,993 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+1.67%-0.16%+21.15% 6.26B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 116B
+0.88%+1.88%+1.66%+36.51% 115B
-2.26%+2.24%-44.03%+5.76% 93.1B
-0.31%-4.72%-3.36%+72.86% 62.09B
-0.09%0.00%+10.58%+84.15% 55.87B
+0.07%+0.42%+5.94%-22.43% 53.12B
+0.30%+1.70%-11.26%+43.83% 44.22B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average +0.04%+1.22%-8.18%+25.97% 75.73B
Weighted average by Cap. -0.12%+1.40%-12.41%+24.15%

Financials

2026 *2027 *
Net sales 2.55B 2.29B 2.12B 1.92B 3.58B 243B 3.63B 25.32B 10.09B 127B 9.58B 9.38B 404B 2.73B 2.45B 2.27B 2.05B 3.84B 260B 3.88B 27.11B 10.8B 136B 10.26B 10.04B 432B
Net income 250M 225M 208M 188M 351M 23.85B 356M 2.48B 989M 12.48B 940M 920M 39.62B 364M 327M 302M 274M 511M 34.7B 518M 3.61B 1.44B 18.16B 1.37B 1.34B 57.65B
Net Debt 1.4B 1.26B 1.16B 1.05B 1.97B 133B 1.99B 13.9B 5.54B 69.85B 5.26B 5.15B 222B 1.22B 1.1B 1.01B 919M 1.72B 117B 1.74B 12.13B 4.83B 60.97B 4.59B 4.49B 194B
Projected Income Statement - Annual - ConvaTec Group Plc
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
26-10-28 GBX 244.00 +1.33% 6,486,679
26-10-27 GBX 240.80 -1.71% 5,414,300
26-10-26 GBX 245.00 -0.49% 7,644,999
26-10-23 GBX 246.20 +0.90% 4,971,574
26-10-22 GBX 244.00 +1.67% 5,479,107
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - ConvaTec Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.248USD
Average target price
4.020USD
Spread / Average Target
+23.77%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ConvaTec Group Plc
  1. Stock Market
  2. Stocks
  3. CTEC Stock